000			01945 a2200577 4500
005			20250517155700.0
264		0	_c20170822
008			201708s 0 0 eng d
022			_a1533-4406
024	7		_a10.1056/NEJMoa1706450 _2doi
040			_aNLM _beng _cNLM
100	1		_aRobson, Mark
245	0	0	_aOlaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation. _h[electronic resource]
260			_bThe New England journal of medicine _c08 2017
300			_a523-533 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntineoplastic Agents _xadverse effects
650	0	4	_aBreast Neoplasms _xdrug therapy
650	0	4	_aChemotherapy, Adjuvant
650	0	4	_aDisease-Free Survival
650	0	4	_aFemale
650	0	4	_aGenes, BRCA1
650	0	4	_aGenes, BRCA2
650	0	4	_aGerm-Line Mutation
650	0	4	_aHumans
650	0	4	_aKaplan-Meier Estimate
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasm Metastasis _xdrug therapy
650	0	4	_aPhthalazines _xadverse effects
650	0	4	_aPiperazines _xadverse effects
650	0	4	_aPoly(ADP-ribose) Polymerase Inhibitors _xadverse effects
650	0	4	_aReceptor, ErbB-2
650	0	4	_aYoung Adult
700	1		_aIm, Seock-Ah
700	1		_aSenkus, Elżbieta
700	1		_aXu, Binghe
700	1		_aDomchek, Susan M
700	1		_aMasuda, Norikazu
700	1		_aDelaloge, Suzette
700	1		_aLi, Wei
700	1		_aTung, Nadine
700	1		_aArmstrong, Anne
700	1		_aWu, Wenting
700	1		_aGoessl, Carsten
700	1		_aRunswick, Sarah
700	1		_aConte, Pierfranco
773	0		_tThe New England journal of medicine _gvol. 377 _gno. 6 _gp. 523-533
856	4	0	_uhttps://doi.org/10.1056/NEJMoa1706450 _zAvailable from publisher's website
999			_c27243196 _d27243196